Internal Medicine Alert
RSSArticles
-
Rate Control in Atrial Fibrillation — Why? How?
Management of atrial fibrillation with a rhythm-control strategy conferred no advantage over a rate-control strategy in cardiac or vascular mortality and may be associated with an increased noncardiovascular death rate. -
Pharmacology Update: Telithromycin Tablets (Ketek)
The FDA has approved telithromycin, the first ketolide antibiotic. -
Clinical Briefs
Alendronate for Osteoporosis; Exercise Training in Patients Chronic Heart Failure; Cardiovascular Prognosis of Masked Hypertension